 NEW YORK, July 21, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma, Inc. Kiromic or the Company NASDAQ: KRBP. Such investors are advised to contact Robert S. 